Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Forte Biosciences Inc (NQ: FBRX ) 0.3166 -0.0024 (-0.75%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Forte Biosciences Inc < Previous 1 2 3 Next > Unusual Options Activity Insight: Forte Biosciences August 06, 2021 On Friday, shares of Forte Biosciences (NASDAQ:FBRX) saw u... Via Benzinga Understanding Forte Biosciences's Unusual Options Activity July 29, 2021 On Thursday, shares of Forte Biosciences (NASDAQ:FBRX) saw unusual options activity. After the option alert, the stock price moved down to $30.99. Sentiment: BULLISH Option Type... Via Benzinga 61 Biggest Movers From Yesterday July 23, 2021 Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy... Via Benzinga Earnings Scheduled For May 10, 2021 May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session July 22, 2021 Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 14, 2021 May 14, 2021 Upgrades Canaccord Genuity upgraded the previous rating for Mogo Inc (NASDAQ:MOGO) from Hold to Speculative Buy. For the first quarter, Mogo had an EPS of $0.06, compared... Via Benzinga The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.